Latest HspE7 Stories
The rate of anal cancer is increasing, particularly among men who have sex with men. A new study shows that a vaccine, used to fight HPV, successfully lowers the rates of anal intraepithelial neoplasia (AIN), which leads to cancer.
The human papillomavirus (HPV) is more likely to be found in tumors of laryngeal cancer patients who are male and those with private health insurance.
New government research shows that two doses of the human papillomavirus (HPV) vaccine may offer just as much protection against cervical cancer as the three-dose treatment.
A widely used HIV drug could be used to prevent cervical cancer caused by infection with the human papilloma virus (HPV), say scientists.
A long-term surveillance strategy for women treated for precancerous cervical lesions may be helping to prevent cervical cancer.
SAN ANTONIO, Feb. 28, 2011 /PRNewswire/ -- Advanced Cell Diagnostics, Inc. (ACD) today announced the results of its clinical study utilizing RNAscope(TM) technology to detect human papillomavirus (HPV) E6/E7 mRNA in routine clinical specimens of head and neck cancer.
BURGESS HILL, England, November 24, 2010 /PRNewswire-FirstCall/ -- - Landmark Study Confirms Accuracy of Roche's Human Papillomavirus Test for the Detection of Cervical Pre-Cancer Missed by Existing Screening Methods The largest ever registrational study for a diagnostic product, involving more than 47,000 women shows that the cobas(R) 4800 Human Papillomavirus (HPV) test from Roche, is able to improve the detection of pre-cancerous cells in women whose cervical smears tested normal.
A study of the options for reducing cancer incidence and mortality among women who have been treated for precancerous cervical lesions found that an annual conventional Pap smear is a cost effective strategy.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.